← Open Payments lookup

AMANDA HOELSCHER: Open Payments

NPI 1700282886 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,755 in 127 payments from 14 companies in 2025. Trend: 2023 $638 · 2024 $1,145 · 2025 $2,755

Food & beverage: $2,128Speaker / faculty: $450Education: $178
CompanyPaymentsAmount
ABBVIE INC.64$1,302
Janssen Biotech, Inc.6$430
PFIZER INC.18$373
Takeda Pharmaceuticals U.S.A., Inc.17$203
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$82
Lilly USA, LLC3$78
Ardelyx, Inc.2$57
Janssen Scientific Affairs, LLC1$54
Phathom Pharmaceuticals, Inc.5$39
VIVUS LLC2$36

Products named: RINVOQ, TREMFYA, SKYRIZI, VELSIPITY, ENTYVIO, CREON, XELJANZ, STELARA.

Industry payments across TX — which companies pay providers there.